FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2123026127> ?p ?o ?g. }

• W2123026127 abstract "We aimed to compare the steady-state pharmacokinetic parameters and tolerability of Triomune 40 (stavudine 40 mg, lamivudine 150 mg and nevirapine 200 mg) and branded formulations of these drugs in HIV-infected Ugandans.This includes a randomized, open-label, cross-over study of HIV-infected patients stable on therapy for 1 month. Patients were randomized to generic or branded formulation. Plasma pharmacokinetics were assessed after 1 month. The following day, alternate formulation was administered, and 1 month later, drug pharmacokinetics were re-assessed. Plasma pharmacokinetics were determined using HPLC-UV detection. Similarity between steady-state pharmacokinetic parameters was assessed using the US Food and Drug Administration standards for bioequivalency testing. Tolerability was assessed using questionnaires.Sixteen (10 females) patients completed the study. Median (IQR) age, weight and CD4 count were 37 (33.7-40) years, 65 (63.4-66) kg and 292 (220.7-344.5) cells/mm(3), respectively. All patients received co-trimoxazole. The geometric mean ratio (90% CI) for stavudine, lamivudine and nevirapine was 0.92 (0.78-1.08), 1.11 (0.95-1.30) and 0.84 (0.64-1.11), respectively, for C(max), and 0.83 (0.70-0.97), 1.06 (0.94-1.20) and 0.88 (0.71-1.10), respectively, for AUC. Stavudine plasma concentrations were significantly lower for the generic formulation. Pharmacokinetic parameter inter-individual variability ranged from 29% to 99%. There were no differences in tolerability for the two formulations.Pharmacokinetic profiles of generic and branded drugs were similar. Differences particularly with regard to stavudine were demonstrated. Surveillance of the quality of generic antiretroviral drugs in the target populations is needed. Capacity building for pharmacokinetic research in resource-limited settings is a priority." @default.
• W2123026127 created "2016-06-24" @default.
• W2123026127 creator A5007876312 @default.
• W2123026127 creator A5021206943 @default.
• W2123026127 creator A5035833238 @default.
• W2123026127 creator A5038706116 @default.
• W2123026127 creator A5041365930 @default.
• W2123026127 creator A5042249868 @default.
• W2123026127 creator A5046080862 @default.
• W2123026127 creator A5051110510 @default.
• W2123026127 creator A5068703662 @default.
• W2123026127 creator A5076836884 @default.
• W2123026127 creator A5077558886 @default.
• W2123026127 creator A5084067321 @default.
• W2123026127 date "2008-07-18" @default.
• W2123026127 modified "2023-10-17" @default.
• W2123026127 title "Steady-state pharmacokinetic comparison of generic and branded formulations of stavudine, lamivudine and nevirapine in HIV-infected Ugandan adults" @default.
• W2123026127 cites W1967825197 @default.
• W2123026127 cites W1978132427 @default.
• W2123026127 cites W2035412462 @default.
• W2123026127 cites W2078579607 @default.
• W2123026127 cites W2117579170 @default.
• W2123026127 cites W2154106992 @default.
• W2123026127 cites W2158809828 @default.
• W2123026127 cites W2317159787 @default.
• W2123026127 doi "https://doi.org/10.1093/jac/dkn290" @default.
• W2123026127 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3596856" @default.
• W2123026127 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18641036" @default.
• W2123026127 hasPublicationYear "2008" @default.
• W2123026127 type Work @default.
• W2123026127 sameAs 2123026127 @default.
• W2123026127 citedByCount "13" @default.
• W2123026127 countsByYear W21230261272012 @default.
• W2123026127 countsByYear W21230261272013 @default.
• W2123026127 countsByYear W21230261272014 @default.
• W2123026127 countsByYear W21230261272017 @default.
• W2123026127 countsByYear W21230261272018 @default.
• W2123026127 crossrefType "journal-article" @default.
• W2123026127 hasAuthorship W2123026127A5007876312 @default.
• W2123026127 hasAuthorship W2123026127A5021206943 @default.
• W2123026127 hasAuthorship W2123026127A5035833238 @default.
• W2123026127 hasAuthorship W2123026127A5038706116 @default.
• W2123026127 hasAuthorship W2123026127A5041365930 @default.
• W2123026127 hasAuthorship W2123026127A5042249868 @default.
• W2123026127 hasAuthorship W2123026127A5046080862 @default.
• W2123026127 hasAuthorship W2123026127A5051110510 @default.
• W2123026127 hasAuthorship W2123026127A5068703662 @default.
• W2123026127 hasAuthorship W2123026127A5076836884 @default.
• W2123026127 hasAuthorship W2123026127A5077558886 @default.
• W2123026127 hasAuthorship W2123026127A5084067321 @default.
• W2123026127 hasBestOaLocation W21230261271 @default.
• W2123026127 hasConcept C112705442 @default.
• W2123026127 hasConcept C126322002 @default.
• W2123026127 hasConcept C142462285 @default.
• W2123026127 hasConcept C159047783 @default.
• W2123026127 hasConcept C197934379 @default.
• W2123026127 hasConcept C2522874641 @default.
• W2123026127 hasConcept C2777869810 @default.
• W2123026127 hasConcept C2778375690 @default.
• W2123026127 hasConcept C2779130552 @default.
• W2123026127 hasConcept C2779889181 @default.
• W2123026127 hasConcept C2780593183 @default.
• W2123026127 hasConcept C2993143319 @default.
• W2123026127 hasConcept C3013748606 @default.
• W2123026127 hasConcept C42404028 @default.
• W2123026127 hasConcept C71924100 @default.
• W2123026127 hasConcept C98274493 @default.
• W2123026127 hasConceptScore W2123026127C112705442 @default.
• W2123026127 hasConceptScore W2123026127C126322002 @default.
• W2123026127 hasConceptScore W2123026127C142462285 @default.
• W2123026127 hasConceptScore W2123026127C159047783 @default.
• W2123026127 hasConceptScore W2123026127C197934379 @default.
• W2123026127 hasConceptScore W2123026127C2522874641 @default.
• W2123026127 hasConceptScore W2123026127C2777869810 @default.
• W2123026127 hasConceptScore W2123026127C2778375690 @default.
• W2123026127 hasConceptScore W2123026127C2779130552 @default.
• W2123026127 hasConceptScore W2123026127C2779889181 @default.
• W2123026127 hasConceptScore W2123026127C2780593183 @default.
• W2123026127 hasConceptScore W2123026127C2993143319 @default.
• W2123026127 hasConceptScore W2123026127C3013748606 @default.
• W2123026127 hasConceptScore W2123026127C42404028 @default.
• W2123026127 hasConceptScore W2123026127C71924100 @default.
• W2123026127 hasConceptScore W2123026127C98274493 @default.
• W2123026127 hasLocation W21230261271 @default.
• W2123026127 hasLocation W21230261272 @default.
• W2123026127 hasLocation W21230261273 @default.
• W2123026127 hasLocation W21230261274 @default.
• W2123026127 hasOpenAccess W2123026127 @default.
• W2123026127 hasPrimaryLocation W21230261271 @default.
• W2123026127 hasRelatedWork W1567838714 @default.
• W2123026127 hasRelatedWork W2055833208 @default.
• W2123026127 hasRelatedWork W2078579607 @default.
• W2123026127 hasRelatedWork W2100366927 @default.
• W2123026127 hasRelatedWork W2123026127 @default.
• W2123026127 hasRelatedWork W2154106992 @default.
• W2123026127 hasRelatedWork W2332057125 @default.
• W2123026127 hasRelatedWork W2411579330 @default.
• W2123026127 hasRelatedWork W4255682891 @default.
• W2123026127 hasRelatedWork W3216155143 @default.
• W2123026127 isParatext "false" @default.

• next